Snowball logo
logo
IMP

Imexpharm Corp

IMP β€’ VN
β‚«37,650.00+β‚«150.00Β  (0.4%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
1,266,596.71,643,706.51,994,036.92,205,119.92,441,085.52,381,916.3
COGS
778,595.4946,351.31,183,501.21,349,562.81,439,521.41,379,313.6
Gross Profit
488,001.3697,355.3810,535.7855,557.21,001,564.11,002,602.7
Operating Expenses & Income
Operating Income
234,071.9296,500.1381,040.9415,258.8462,435.4476,683.6
Total Operating Expenses
1,032,524.81,347,206.41,612,9961,789,861.11,978,6501,905,232.8
R&D Expenses
------
Selling General & Admin Expenses
124,246.6212,918.6235,504.5229,178.5299,415.9469,489.8
Earnings from Continuing Operations
Interest Expense
(5,496.3)(3,794.6)(6,036.2)(3,489.4)(16,501.4)(15,125)
Interest Income
7,886.713,861.316,885.37,884.116,137.926,339.3
Income Tax Expense
49,764.2-----
Net Income
Net Income
189,094.9223,540.3299,556320,862.4349,138373,731
Supplemental
EBIT
234,071.9-----
EBITDA
304,767.5355,584.4----
In millions of VND, except % and values per 1 share